Improving physicians' recognition and treatment of depression in general medical care. Results from a randomized clinical trial

Medical Care
K Magruder-HabibJ R Feussner

Abstract

A randomized clinical trial was performed to assess whether the results of a depression screening instrument, when provided to physicians, could influence their recognition and treatment of depression in a primary care setting. The intervention consisted of randomly informing or not informing physicians of the depression status of 100 patients who screened positively for depression on both the Zung Self-rating Depression Scale (SDS) and a DSM-III screen. For 12 months patients were followed to assess depression status, and medical records were audited to assess depression recognition and treatment. Results show that feedback to physicians of SDS scores of previously unrecognized depressed patients makes a significant difference in greater recognition (56.2% vs. 34.6%) and treatment (56.2% vs. 42.3%) of depression over the 12-month study period. This was especially true for patients with high somatic (P less than 0.05) or low psychologic symptoms of depression (P less than 0.05). These results suggest that routine use of a depression screening instrument can improve physician recognition of depression, with increased initiation of treatment.

Citations

Sep 1, 1992·Journal of General Internal Medicine·D G BuchsbaumM J Lawton
Jan 5, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·J M ValderasJ Alonso
Dec 24, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Joanne Greenhalgh
Nov 4, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Claire F SnyderMaria Santana
Jun 16, 2010·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Rebecca SchnallSuzanne Bakken
Apr 3, 2003·Journal of Psychosomatic Research·Steven C Palmer, James C Coyne
Feb 1, 1997·Journal of Psychosomatic Research·J D LishM Zimmerman
Jul 9, 2002·General Hospital Psychiatry·John W WilliamsChristina Perez Stellato
Jul 1, 1997·General Hospital Psychiatry·C C McLeodD C McClelland
Jul 17, 1998·Social Science & Medicine·I H ThaverP Garner
Jun 16, 1999·Social Science & Medicine·J W Robinson, D L Roter
Dec 13, 2002·Patient Education and Counseling·Betsy Sleath, Richard H Rubin
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G VelikovaP Selby
Feb 24, 2001·The Journal of Ambulatory Care Management·S A Boren, E A Balas
Feb 17, 2001·BMJ : British Medical Journal·S M GilbodyT A Sheldon
Apr 8, 2003·Quality & Safety in Health Care·S M GilbodyR E Thomas
Feb 7, 1993·Quality in Health Care : QHC·N FreemantleA F Long
Jan 1, 1996·Annual Review of Medicine·G S Norquist, D A Regier
Jun 14, 2012·BMC Medical Research Methodology·Felicity A Goodyear-SmithChris Del Mar
Sep 16, 2000·Social Work in Health Care·B D Rock, M Cooper
Apr 9, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Simon GilbodyAllan House
Jan 26, 2010·Primary Care Companion to the Journal of Clinical Psychiatry·Hillary R BognerHeather F de Vries
Sep 16, 2005·Primary Care Companion to the Journal of Clinical Psychiatry·André Tylee, Paul Gandhi
Jun 5, 2012·Journal of Affective Disorders·Christina BarrickDianne Taylor
Mar 11, 2003·Journal of Women's Health·L Douglas Ried, Lourdes G Planas
Jul 23, 2002·Journal of General Internal Medicine·Bruce L RollmanHerbert C Schulberg
Jan 30, 2004·Journal of General Internal Medicine·David JarjouraGregory Rutecki
Jun 24, 2004·Journal of General Internal Medicine·Robert D KeeleyKathryn M Rost
Sep 15, 2001·Journal of General Internal Medicine·E H LinS D Pearson
Dec 31, 1997·Journal of General Internal Medicine·M ValensteinA Douglass
Jul 1, 1996·Journal of General Internal Medicine·T L Schwenk
Apr 1, 1996·Journal of General Internal Medicine·C M CallahanW M Tierney
Feb 16, 1999·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·L A AndersonC Jenkins
Nov 1, 1996·General Hospital Psychiatry·H C SchulbergF deGruy
Jul 26, 2008·Journal of the American Pharmacists Association : JAPhA·Dan E KnightNick C Patel
May 13, 1999·The American Journal of Medicine·J W WilliamsS Lee
Oct 3, 2007·Mayo Clinic Proceedings·Marlene H FrostUNKNOWN Clinical Significance Consensus Meeting Group
Oct 3, 2007·Mayo Clinic Proceedings·Elizabeth A HahnUNKNOWN Clinical Significance Consensus Meeting Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.